A patient has pelvic pain and purulent-appearing discharge. Most
likely pathogen?
A. HSV-1
B. VZV
C. HSV-2
D. CMV
C. HSV-2
During active genital HSV, latency is established in:
A.
Lumbosacral nerve ganglia
B. Dorsal root ganglia
(cervical)
C. Trigeminal ganglion
D. Enteric plexuses
A. Lumbosacral nerve ganglia
Pregnant patient with primary active genital HSV at delivery. Best
management?
A. Vaginal delivery, observe lesions
B.
Vacuum-assisted vaginal delivery
C. Forceps-assisted vaginal
delivery
D. Cesarean section
D. Cesarean section
Molluscum contagiosum is caused by a:
A. Herpesvirus
B.
Poxvirus
C. Papillomavirus
D. Adenovirus
B. Poxvirus
MCV-2 is most commonly transmitted via:
A. Sexual
contact
B. Fomites
C. Respiratory droplets
D. Insect vectors
A. Sexual contact
Pearly dome-shaped papules with central dimple suggest:
A.
Condyloma acuminatum
B. Genital herpes
C. Molluscum
contagiosum
D. Syphilitic chancre
C. Molluscum contagiosum
Molluscum viral inclusions are located in the:
A.
Nucleolus
B. Cytoplasm
C. Mitochondria
D. ER lumen
B. Cytoplasm
Thick vulvovaginal erythema and swelling with “curd-like” discharge
is most associated with:
A. Trichomonas vaginalis
B.
HSV-2
C. Molluscum contagiosum
D. Candida
D. Candida
The discharge classically described for Candida is:
A. Curd-like
discharge
B. Thin gray discharge
C. Frothy green
discharge
D. Bloody mucoid discharge
A. Curd-like discharge
Trichomonas vaginalis is best described as a:
A. Encapsulated
yeast
B. Gram-negative diplococcus
C. Flagellated
protozoan
D. Obligate intracellular bacterium
C. Flagellated protozoan
Post–spontaneous/induced abortion infections that can cause PID are
often:
A. Chlamydial infections
B. Puerperal
infections
C. Viral infections
D. Mycobacterial infections
B. Puerperal infections
Puerperal infections spread upward via:
A. Direct arterial
spread
B. Perineural spread
C. Lymphatic and venous
channels
D. Transplacental spread
C. Lymphatic and venous channels
Compared with gonococcal PID, puerperal infections tend to
inflame:
A. Deeper organ layers
B. Superficial
mucosa
C. Cervical epithelium
D. Serosal surfaces
A. Deeper organ layers
Smooth white vulvar plaques that enlarge/coalesce suggest:
A.
Vulvar papillomatosis
B. Lichen sclerosus
C. Squamous
papilloma
D. Trichomoniasis
B. Lichen sclerosus
Advanced lichen sclerosus can lead to:
A. Labial
hypertrophy
B. Cervical dilation
C. Endometrial
hypertrophy
D. Constricted vaginal orifice
D. Constricted vaginal orifice
Key histologic feature of lichen sclerosus is:
A. Epidermal
thinning
B. Epidermal acanthosis
C. Full-thickness
atypia
D. Koilocytosis
A. Epidermal thinning
Squamous cell hyperplasia (lichen simplex chronicus) is driven
by:
A. HPV integration
B. Chronic scratching/rubbing
C.
Estrogen deficiency
D. Acute gonococcal infection
B. Chronic scratching/rubbing
Squamous cell hyperplasia is characterized by:
A. Dermal mucin
deposition
B. Epidermal thinning
C. Loss of rete
ridges
D. Epidermal thickening
D. Epidermal thickening
Both lichen sclerosus and squamous hyperplasia often show:
A.
Koilocytosis
B. Full-thickness dysplasia
C.
Hyperkeratosis
D. Caseating granulomas
C. Hyperkeratosis
Vulvar squamous papillomas are best described as:
A. Malignant
ulcerative tumors
B. Benign exophytic papilloma
C. Pigmented
melanocytic lesions
D. Deep infiltrative nodules
B. Benign exophytic papilloma
Most common histologic type of vulvar cancer is:
A. Basal cell
carcinoma
B. Adenocarcinoma
C. Squamous cell
carcinoma
D. Melanoma
C. Squamous cell carcinoma
Basaloid and warty vulvar carcinomas arise from:
A.
Differentiated VIN
B. Lichen sclerosus
C. Squamous
papillomatosis
D. Classic VIN
D. Classic VIN
Keratinizing vulvar SCC most often arises from:
A. Classic
VIN
B. Squamous papilloma
C. Papillary hidradenoma
D.
Differentiated VIN
D. Differentiated VIN
Differentiated VIN is most associated with a history of:
A.
Recurrent trichomoniasis
B. Chronic lichen sclerosus
C.
Primary HSV infection
D. Molluscum contagiosum
B. Chronic lichen sclerosus
A sharply circumscribed nodule on labia majora/interlabial fold
suggests:
A. Bartholin cyst
B. VIN lesion
C. Papillary
hidradenoma
D. Condyloma lata
C. Papillary hidradenoma
Papillary hidradenoma histology shows:
A. Sheets of atypical
keratinocytes
B. Koilocytes with perinuclear halos
C.
Granulomatous inflammation
D. Two-layer glandular lining
D. Two-layer glandular lining
Basaloid and warty vulvar carcinomas are:
A. Unrelated to
HPV
B. HPV-related
C. Always estrogen-driven
D. Always
postmenopausal only
B. HPV-related
Basaloid and warty vulvar carcinomas typically occur:
A. At
younger ages
B. Only after menopause
C. Only during
pregnancy
D. Only in adolescence
A. At younger ages
A vulvar carcinoma subtype is not HPV-related. Which is
it?
A. Basaloid squamous carcinoma
B. Warty squamous
carcinoma
C. Keratinizing squamous carcinoma
D. Clear cell carcinoma
C. Keratinizing squamous carcinoma
Keratinizing vulvar SCC occurs most often in:
A. Older
women
B. Teenagers
C. Children
D. Pregnant patients
A. Older women
Keratinizing vulvar SCC is best described as:
A. Rare, younger
onset
B. Equal to warty types
C. Less common than
basaloid
D. More common than warty
D. More common than warty
Pruritic red, crusted, maplike vulvar lesion suggests:
A. Lichen
sclerosus
B. Extramammary Paget disease
C. Squamous
papilloma
D. Condyloma lata
B. Extramammary Paget disease
Extramammary Paget disease is usually on the:
A. Labia
majora
B. Cervix
C. Endocervix
D. Vaginal fornix
A. Labia majora
A lateral vaginal wall cyst from duct rests is:
A. Müllerian
cyst
B. Gartner duct cyst
C. Bartholin cyst
D.
Nabothian cyst
B. Gartner duct cyst
Gartner duct cysts are most often found on the:
A. Posterior
vaginal wall
B. Cervical os
C. Labia minora
D. Lateral
vaginal walls
D. Lateral vaginal walls
Gartner duct cysts are typically:
A. Submucosal, fluid-filled
cysts
B. Solid ulcerated plaques
C. Keratin-filled
epidermoid cysts
D. Deep infiltrative masses
A. Submucosal, fluid-filled cysts
Virtually all primary vaginal cancers are:
A.
Adenocarcinoma
B. Melanoma
C. Squamous cell
carcinoma
D. Leiomyosarcoma
C. Squamous cell carcinoma
Primary vaginal SCC is strongly associated with:
A. Low-risk
HPV
B. EBV infection
C. HSV infection
D. High-risk HPV
D. High-risk HPV
Vaginal SCC often arises from a premalignant:
A. CIN
B.
VAIN
C. VIN
D. AIS
B. VAIN
The cervical site most susceptible to HPV is:
A. Mature
ectocervix
B. Endocervical glands
C. Immature metaplastic
cells
D. Myometrial smooth muscle
C. Immature metaplastic cells
HPV primarily infects which epithelial cells?
A. Immature basal
cells
B. Mature superficial cells
C. Keratinized surface
cells
D. Columnar ciliated cells
A. Immature basal cells
HPV cannot infect directly the:
A. Basal squamous cells
B.
Mature superficial squamous cells
C. Immature metaplastic
cells
D. Parabasal squamous cells
B. Mature superficial squamous cells
HPV infection of vagina/vulva usually requires:
A. Intact
epithelium
B. High progesterone
C. High estrogen
D.
Surface epithelial damage
D. Surface epithelial damage
Low-risk HPV dysregulates growth via:
A. Wnt pathway
B.
Notch pathway
C. Hedgehog pathway
D. TGF-β pathway
B. Notch pathway
LSIL typically shows HPV replication that is:
A. Absent
B.
Low
C. High
D. Integrated only
C. High
Most LSIL lesions:
A. Regress spontaneously
B. Metastasize
early
C. Require hysterectomy
D. Progress rapidly
A. Regress spontaneously
In HSIL, HPV replication tends to be:
A. Very high
B.
Unchanged
C. Variable
D. Low
D. Low
HSIL most characteristically shows:
A. Normal maturation
B.
Increased maturation
C. Arrested epithelial maturation
D.
Keratin pearl formation
C. Arrested epithelial maturation
HSIL carries a:
A. Negligible cancer risk
B. High cancer
progression risk
C. Risk only in pregnancy
D. Risk only postmenopause
B. High cancer progression risk
A benign exophytic lesion causing spotting arises in the:
A.
Ectocervix surface
B. Vaginal introitus
C. Labia
majora
D. Endocervical canal
D. Endocervical canal
Endocervical polyps contain:
A. Dense collagen stroma
B.
Caseating granulomas
C. Loose fibromyxoid stroma
D. Solid
atypical nests
C. Loose fibromyxoid stroma
Endocervical polyps commonly present with:
A. Thick curd
discharge
B. Irregular bleeding/spotting
C. Frothy green
discharge
D. Vesicular vulvar pain
B. Irregular bleeding/spotting
Endocervical polyps are lined by:
A. Mucus-secreting
endocervical glands
B. Keratinized squamous epithelium
C.
Transitional urothelium
D. Ciliated tubal epithelium
A. Mucus-secreting endocervical glands
HPV reaches target cells mainly through:
A. Hematogenous
spread
B. Lymphatic invasion
C. Epithelial breaks at
SCJ
D. Transplacental passage
C. Epithelial breaks at SCJ
HSIL reflects progressive cell-cycle deregulation by:
A.
Candida
B. HPV
C. HSV
D. MCV
B. HPV
Gartner duct cysts derive from:
A. Müllerian duct
B.
Urogenital sinus
C. Cloacal membrane
D. Wolffian duct
D. Wolffian duct
Which IHC pair is most associated with HPV-related SIL?
A. ER
and PR
B. CD3 and CD20
C. Ki-67 and p16
D. PAS and mucicarmine
C. Ki-67 and p16
Why can Ki-67 appear in upper epithelium in HPV lesions?
A.
E6/E7 block cell-cycle arrest
B. p53 hyperactivation halts
mitosis
C. Estrogen withdrawal accelerates turnover
D.
Hypoxia induces senescence pathways
A. E6/E7 block cell-cycle arrest
Most common HPV type in both LSIL/HSIL?
A. HPV-6
B.
HPV-11
C. HPV-18
D. HPV-16
D. HPV-16
About what fraction of LSIL is HPV-associated?
A. About
20%
B. About 80%
C. About 40%
D. About 60%
B. About 80%
About what fraction of HSIL is HPV-associated?
A. Nearly
100%
B. About 80%
C. About 60%
D. About 40%
A. Nearly 100%
Most common histologic subtype of cervical cancer?
A. Small cell
carcinoma
B. Adenosquamous carcinoma
C. Squamous cell
carcinoma
D. Clear cell carcinoma
C. Squamous cell carcinoma
Second most common cervical cancer type is:
A. Neuroendocrine
carcinoma
B. Adenocarcinoma
C. Squamous cell
carcinoma
D. Sarcoma botryoides
B. Adenocarcinoma
Precursor lesion for cervical adenocarcinoma?
A. CIN III
B.
Classic VIN
C. Differentiated VIN
D. Adenocarcinoma in situ
D. Adenocarcinoma in situ
Tumor with malignant glandular + squamous cells?
A.
Adenosquamous carcinoma
B. Adenocarcinoma
C. Squamous
carcinoma
D. Neuroendocrine carcinoma
A. Adenosquamous carcinoma
Which category tends to progress faster and worse?
A.
Keratinizing squamous carcinomas
B. Classic VIN lesions
C.
Adenocarcinoma and neuroendocrine
D. Endocervical polyps
C. Adenocarcinoma and neuroendocrine
Advanced cervical carcinoma spreads mainly by:
A. Hematogenous
dissemination
B. Direct extension
C. Transcoelomic
seeding
D. Perineural invasion
B. Direct extension
Cervical cancer confined to cervix is stage:
A. Stage II
B.
Stage III
C. Stage I
D. Stage IV
C. Stage I
Carcinoma in situ (CIN III/HSIL) is stage:
A. Stage 0
B.
Stage I
C. Stage II
D. Stage III
A. Stage 0
Beyond cervix, not pelvic wall; vagina not lower third:
A. Stage
III
B. Stage II
C. Stage IV
D. Stage I
B. Stage II
Pelvic wall involvement and lower third vagina:
A. Stage
I
B. Stage II
C. Stage IV
D. Stage III
D. Stage III
Beyond true pelvis or bladder/rectum mucosa:
A. Stage IV
B.
Stage III
C. Stage II
D. Stage I
A. Stage IV
Rectal exam shows no tumor-free space. Stage?
A. Stage
II
B. Stage IV
C. Stage III
D. Stage I
C. Stage III
Hydronephrosis in cervical cancer suggests extension to:
A.
Paracervical soft tissue
B. Ureters
C. Vagina
D. Rectum
B. Ureters
HPV vaccination is routinely recommended for:
A. Girls
only
B. Boys only
C. Pregnant patients only
D. Girls
and boys
D. Girls and boys
Anovulatory cycles cause endometrium exposure to:
A. Excess
progesterone
B. Excess androgens
C. Unopposed
estrogens
D. Unopposed inhibin
C. Unopposed estrogens
Anovulatory endometrium typically lacks:
A. Glandular secretory
changes
B. Squamous metaplasia
C. Koilocytosis
D. Viral inclusions
A. Glandular secretory changes
Another progesterone-dependent feature absent in anovulation:
A.
Increased mitoses only
B. Basal vacuolization only
C.
Keratin pearl formation
D. Stromal predecidualization
D. Stromal predecidualization
Progesterone is absent in anovulation because:
A. Placenta fails
to form
B. No corpus luteum forms
C. Theca cells stop
aromatase
D. Pituitary secretes excess prolactin
B. No corpus luteum forms
Postpartum fever with uterine tenderness most suggests:
A.
Chronic endometritis
B. Endometriosis
C. Cervical
ectropion
D. Acute endometritis
D. Acute endometritis
Acute endometritis is most linked to infections after:
A. Ovulation
B. Delivery or miscarriage
C.
Menopause
D. HPV vaccination
B. Delivery or miscarriage
Endometriosis is best defined as:
A. Ectopic endometrial tissue
outside uterus
B. Endometrial atrophy in uterus
C. Tubal
squamous metaplasia
D. Cervical gland hyperplasia
A. Ectopic endometrial tissue outside uterus
Most common site for endometriosis is:
A. Myometrium
B.
Cervix
C. Ovaries
D. Liver capsule
C. Ovaries
A common endometriosis location is the:
A. Fallopian
fimbriae
B. Rectovaginal septum
C. Urinary bladder
mucosa
D. Ovarian medulla
B. Rectovaginal septum
In HPV-related SIL, Ki-67 staining often extends into:
A. Basal
layer
B. Stromal fibroblasts
C. Glandular lumen
D.
Upper epithelial layers
D. Upper epithelial layers
Strong p16 staining most supports:
A. Candida infection
B.
HSV infection
C. High-risk HPV infection
D. Trichomonas infection
C. High-risk HPV infection
Roughly what percent of cervical cancers are SCC?
A. About
80%
B. About 15%
C. About 5%
D. About 40%
A. About 80%
Endometriotic stromal cells generate excess estrogen due to
increased:
A. 5α-reductase activity
B. Sulfatase
activity
C. Aromatase expression
D. COMT activity
C. Aromatase expression
Endometriosis has been reported in men treated for prostate cancer
with:
A. High-dose estrogens
B. High-dose androgens
C.
Radiation alone
D. GnRH agonists only
A. High-dose estrogens
A medication class beneficial in endometriosis targets which
enzyme?
A. COX-1
B. 5α-reductase
C. Desmolase
D. Aromatase
D. Aromatase
Which hormone most directly enhances persistence of endometriotic
tissue?
A. Progesterone
B. Estrogen
C. Inhibin
D. Prolactin
B. Estrogen
A woman with endometriosis has higher risk for certain ovarian
cancers. The underlying condition is:
A. Endometriosis
B.
Adenomyosis
C. Endometritis
D. PCOS
A. Endometriosis
Likely precursor to endometriosis-related ovarian carcinoma:
A.
Adenomyosis
B. Endometrial polyp
C. Atypical
endometriosis
D. Non-atypical hyperplasia
C. Atypical endometriosis
Adenomyosis is defined as endometrial tissue within the:
A.
Serosa
B. Myometrium
C. Endocervix
D. Vagina
B. Myometrium
Microscopy shows irregular stromal nests ± glands within uterine
wall. Diagnosis?
A. Endometrial polyp
B. Endometrial
hyperplasia
C. Endometriosis
D. Adenomyosis
D. Adenomyosis
Endometrial polyps can come from using:
A. Letrozole
B.
Leuprolide
C. Tamoxifen
D. Clomiphene
C. Tamoxifen
Tamoxifen’s tissue-selective action is best described as:
A.
Agonist breast, antagonist endometrium
B. Antagonist breast,
agonist endometrium
C. Antagonist breast, antagonist
endometrium
D. Agonist breast, agonist endometrium
B. Antagonist breast, agonist endometrium
A common cause of abnormal uterine bleeding and frequent precursor to
carcinoma:
A. Adenomyosis
B. Endometriosis
C.
Cervicitis
D. Endometrial hyperplasia
D. Endometrial hyperplasia
Endometrial hyperplasia is most strongly linked to:
A. Prolonged
estrogenic stimulation
B. Chronic progesterone exposure
C.
High prolactin states
D. Acute bacterial infection
A. Prolonged estrogenic stimulation
The estrogen source driving hyperplasia may be:
A. Only
ovarian
B. Endogenous or exogenous
C. Only exogenous
D.
Only adrenal
B. Endogenous or exogenous
Common genetic alteration in hyperplasia and endometrial
carcinoma:
A. APC loss
B. BRCA1 loss
C. RB1
loss
D. PTEN inactivation
D. PTEN inactivation
PTEN loss most directly overactivates which pathway?
A. PI3K/AKT
pathway
B. JAK/STAT pathway
C. Notch pathway
D.
Hedgehog pathway
A. PI3K/AKT pathway
Germline PTEN mutations causing high endometrial cancer risk:
A.
Lynch syndrome
B. Li-Fraumeni syndrome
C. Cowden
syndrome
D. Peutz-Jeghers syndrome
C. Cowden syndrome
Cowden syndrome is strongly associated with increased:
A. Colon
and gastric cancers
B. Ovarian and pancreatic cancers
C.
Liver and lung cancers
D. Breast and endometrial cancers
D. Breast and endometrial cancers
Endometrial hyperplasia is classified as:
A. Non-atypical or
atypical
B. Serous or mucinous
C. Diffuse or nodular
D.
Simple or cystic
A. Non-atypical or atypical
Atypical endometrial hyperplasia is also called:
A. VIN
B.
VAIN
C. Endometrial intraepithelial neoplasia
D.
Adenocarcinoma in situ
C. Endometrial intraepithelial neoplasia
Cardinal feature of non-atypical hyperplasia:
A. Stromal
invasion
B. Increased gland-to-stroma ratio
C.
Koilocytosis
D. Caseating granulomas
B. Increased gland-to-stroma ratio
Atypical hyperplasia is best described as:
A. Complex glands
with nuclear atypia
B. Simple glands without atypia
C. Pure
stromal overgrowth
D. Surface ulceration only
A. Complex glands with nuclear atypia
Most common type of endometrial carcinoma:
A. Type II
carcinoma
B. Clear cell carcinoma
C. Serous
carcinoma
D. Type I carcinoma
D. Type I carcinoma
Enzyme high in endometriotic stroma but absent in normal endometrial
stroma:
A. 5α-reductase
B. Aromatase
C. DNMT1
D. Myeloperoxidase
B. Aromatase
Endometriosis increases risk of which ovarian cancer
subtypes?
A. Serous and mucinous
B. Dysgerminoma and yolk
sac
C. Endometrioid and clear cell
D. Granulosa and thecoma
C. Endometrioid and clear cell
Estrogen’s main effect in endometriosis is to:
A. Induce rapid
tissue necrosis
B. Enhance tissue survival
C. Block
aromatase transcription
D. Prevent stromal proliferation
B. Enhance tissue survival
A uterine wall lesion containing endometrial stroma ± glands is
located in the:
A. Endometrium
B. Cervical stroma
C.
Myometrium
D. Vaginal submucosa
C. Myometrium
Tamoxifen-associated endometrial polyps best reflect tamoxifen acting
as:
A. Weak endometrial estrogen agonist
B. Pure endometrial
estrogen antagonist
C. Pure progesterone agonist
D.
Aromatase inhibitor
A. Weak endometrial estrogen agonist
Complex gland crowding with nuclear atypia is:
A. Atypical
hyperplasia
B. Non-atypical hyperplasia
C. Endometrial
polyp
D. Adenomyosis
A. Atypical hyperplasia
Type I endometrial carcinomas are also called:
A. Serous
carcinomas
B. Clear cell carcinomas
C. Endometrioid
carcinomas
D. Mixed Müllerian tumors
C. Endometrioid carcinomas
Type I endometrioid carcinoma typically arises in the setting
of:
A. Endometrial atrophy
B. Endometrial
hyperplasia
C. Cervical dysplasia
D. Myometrial fibrosis
B. Endometrial hyperplasia
Type I tumors share risk factors with hyperplasia, including:
A. Obesity and diabetes
B. Smoking and HPV
C. Early
menopause only
D. Hyperprolactinemia
A. Obesity and diabetes
Atypical hyperplasia and endometrial carcinoma commonly share
mutations in:
A. TP53
B. PTEN
C. RB1
D. APC
B. PTEN
This supports atypical hyperplasia as a:
A. Late metastasis
marker
B. Precursor to carcinoma
C. Non-neoplastic
change
D. Treatment complication
B. Precursor to carcinoma
Common mutations in type I endometrioid carcinomas increase signaling
through:
A. MAPK/ERK
B. JAK/STAT
C. PI3K/AKT
D. Notch
C. PI3K/AKT
PI3K/AKT signaling in endometrial cells tends to augment:
A.
Androgen receptor targets
B. Estrogen receptor targets
C.
Progesterone receptor targets
D. p53-dependent targets
B. Estrogen receptor targets
Endometrioid carcinoma gross pattern can be:
A. Only diffuse
infiltrative
B. Only polypoid
C. Ulcerative
D. Local
polypoid or diffuse
D. Local polypoid or diffuse
Typical spread for endometrioid carcinoma occurs via:
A.
Lymphatics invasion then extension
B. Hematogenous invasion then
extension
C. Myometrial invasion then extension
D.
Transcoelomic invasion then extension
C. Myometrial invasion then extension
Endometrioid adenocarcinomas are characterized by glands
resembling:
A. Tubal epithelium
B. Normal endometrial
epithelium
C. Squamous epithelium
D. Cervical mucus glands
B. Normal endometrial epithelium
Type II endometrial carcinomas most often arise in:
A.
Hyperplasia
B. Endometrial atrophy
C. Pregnancy
D. Endometritis
B. Endometrial atrophy
Type II (serous) carcinomas are by definition:
A. Well
differentiated
B. Poorly differentiated
C. Low grade
D. Benign
B. Poorly differentiated
Most common subtype of type II endometrial carcinoma:
A.
Endometrioid
B. Mucinous
C. Serous carcinoma
D. Adenosquamous
C. Serous carcinoma
Tumor suppressor mutated in ≥90% of serous carcinomas:
A.
PTEN
B. BRCA1
C. TP53
D. MLH1
C. TP53
Precursor lesion of serous endometrial carcinoma:
A. EIN
B. Endometrial intraepithelial carcinoma
C. CIN III
D. VAIN
B. Endometrial intraepithelial carcinoma
Endometrial intraepithelial carcinoma consists of:
A. Cells
identical to serous carcinoma
B. Benign glands only
C.
Stromal invasion present
D. Squamous metaplasia only
A. Cells identical to serous carcinoma
Serous carcinomas often arise in:
A. Enlarged gravid
uteri
B. Small atrophic uteri
C. Hypertrophic uteri
D. Adolescent uteri
B. Small atrophic uteri
Serous carcinomas are often:
A. Tiny and superficial
B.
Bulky or deeply invasive
C. Always polypoid only
D. Always mucinous
B. Bulky or deeply invasive
Incidence of endometrial carcinoma peaks in:
A. Teen
years
B. 20–30
C. 35–45
D. Postmenopausal 55–65
D. Postmenopausal 55–65
Serous carcinoma occurs more frequently in women of:
A. Asian
descent
B. African American descent
C. Native American
descent
D. Hispanic descent
B. African American descent
Serous carcinoma contributes to mortality in African American women
being:
A. 2-fold higher
B. 10-fold higher
C. Equal
to Caucasian women
D. Lower than Caucasian women
A. 2-fold higher
Typical presenting symptom aiding early detection for Serous
carcinoma:
A. Purulent cervical discharge
B.
Postmenopausal vaginal bleeding
C. Cyclic pelvic pain only
D. Urinary retention
B. Postmenopausal vaginal bleeding
For Serous carcinoma, Postmenopausal bleeding may occur with:
A. Excess leukorrhea
B. Frothy green discharge
C. Curdy
discharge
D. Vesicular lesions
A. Excess leukorrhea
Malignant mixed Müllerian tumors are typically:
A. Small and
cystic
B. Bulky/polypoid
C. Flat plaques
D.
Papillary fronds only
B. Bulky/polypoid
Histology of malignant mixed Müllerian tumor shows:
A. Pure
adenocarcinoma only
B. Adenocarcinoma + malignant
mesenchyme
C. Pure sarcoma only
D. Pure squamous nests
B. Adenocarcinoma + malignant mesenchyme
Malignant mixed Müllerian tumors most often occur in:
A.
Premenopausal teens
B. Postmenopausal women
C. Pregnant
women
D. Men
B. Postmenopausal women
Typical presentation of malignant mixed Müllerian tumors:
A.
Vaginal bleeding
B. Painless vulvar papules
C. Amenorrhea
only
D. Galactorrhea
A. Vaginal bleeding
Diagnosis of adenosarcoma requires:
A. Malignant glands, benign
stroma
B. Malignant stroma, benign abnormal glands
C.
Benign glands, benign stroma
D. Malignant glands, malignant stroma
B. Malignant stroma, benign abnormal glands
Adenosarcomas are commonly seen in:
A. 4th–5th decade
B.
1st–2nd decade
C. 7th–8th decade
D. Childhood only
A. 4th–5th decade
Adenosarcomas are generally:
A. High grade aggressive
B.
Low grade malignancy
C. Always metastatic
D. Always benign
B. Low grade malignancy
Type I endometrioid tumors are associated with unopposed:
A.
Estrogen stimulation
B. Progesterone stimulation
C.
Inhibin stimulation
D. Oxytocin stimulation
A. Estrogen stimulation
Oophorectomy benefits endometrial stromal adenosarcoma because
of:
A. Progesterone replacement effect
B. HPV eradication
mechanism
C. Estrogen withdrawal effect
D. Iron chelation effect
C. Estrogen withdrawal effect
Low-grade endometrial stromal sarcoma commonly shows:
A.
JAZF1–SUZ12 fusion
B. PTEN–TP53 fusion
C. MED12–RB1
fusion
D. KRAS–APC fusion
A. JAZF1–SUZ12 fusion
JAZF1 most directly encodes a:
A. Histone
acetyltransferase
B. Cell-surface receptor
C. Spindle
checkpoint kinase
D. Transcriptional repressor
D. Transcriptional repressor
SUZ12 is best linked to:
A. Microtubule polymerization
B.
Repressive histone marks
C. Steroid hormone cleavage
D.
Viral capsid assembly
B. Repressive histone marks
MED12 mutations occur in ~70% of uterine:
A. Endometrial
polyps
B. Leiomyomas
C. Granulosa tumors
D. Stromal sarcomas
B. Leiomyomas
MED12 mutations are virtually unique to:
A. Müllerian epithelial
tumors
B. Germ cell tumors
C. Sex cord tumors
D.
Uterine smooth muscle tumors
D. Uterine smooth muscle tumors
MED12 mutations are seen in:
A. Leiomyomas and
leiomyosarcomas
B. Adenomatoid tumors only
C. Paratubal
cysts only
D. Serous carcinomas only
A. Leiomyomas and leiomyosarcomas
A uterine leiomyosarcoma most often metastasizes by:
A.
Perineural spread
B. Transcoelomic seeding
C. Hematogenous
spread
D. Direct extension only
C. Hematogenous spread
Most typical distant metastasis site for leiomyosarcoma:
A.
Thyroid
B. Lungs
C. Spleen
D. Pancreas
B. Lungs
Distant spread pattern most consistent with leiomyosarcoma:
A.
Omentum, peritoneum, ovaries
B. Pelvic nodes, inguinal
nodes
C. Skin, liver, adrenal
D. Lung, bone, brain
D. Lung, bone, brain
Regurgitation theory of endometriosis proposes ectopic implants
via:
A. Direct cervical invasion
B. Sexual
transmission
C. Retrograde menstrual flow
D. Hematogenous
emboli only
C. Retrograde menstrual flow
“Benign metastases” theory proposes endometriosis spreads
via:
A. Blood and lymphatics
B. Retrograde flow only
C.
Surface inoculation only
D. Ovulation-related rupture
A. Blood and lymphatics
Most common primary fallopian tube lesion:
A. Serous
carcinoma
B. Salpingitis nodosa
C. Endometriosis
plaque
D. Paratubal cysts
D. Paratubal cysts
Paratubal cysts are typically:
A. Solid nodules,
hemorrhagic
B. Translucent cysts, clear fluid
C. Papillary
masses, mucin-filled
D. Ulcerated plaques, crusted
B. Translucent cysts, clear fluid
Benign fallopian tube tumor is usually:
A. Adenomatoid
tumor
B. Dysgerminoma
C. Brenner tumor
D. Choriocarcinoma
A. Adenomatoid tumor
Tubal adenomatoid tumors often occur:
A. Intramucosal
only
B. Endometrial stroma only
C. Subserosal or
mesosalpinx
D. Cervical transformation zone
C. Subserosal or mesosalpinx
Tubal adenomatoid tumor counterpart occurs in:
A.
Endocervix
B. Breast ducts
C. Bartholin gland
D. Testis
or epididymis
D. Testis or epididymis
PCOS is best defined by:
A. Hyperandrogenism with chronic
anovulation
B. Hypoandrogenism with ovulation
C.
Progesterone excess only
D. Estrogen deficiency only
A. Hyperandrogenism with chronic anovulation
PCOS reflects dysregulation of enzymes in:
A. Collagen
synthesis
B. Androgen biosynthesis
C. Heme synthesis
D.
Bile acid synthesis
B. Androgen biosynthesis
PCOS increases endometrial risk via increased free:
A.
Progesterone
B. Testosterone
C. Estrone
D. Inhibin
C. Estrone
In PCOS, increased free estrone raises risk of:
A. Cervical
dysplasia
B. Ovarian torsion
C. Vaginal SCC
D.
Endometrial hyperplasia/carcinoma
D. Endometrial hyperplasia/carcinoma
Stromal hyperthecosis is seen most often in:
A.
Adolescents
B. Postmenopausal women
C. Pregnancy
D.
Prepubertal girls
B. Postmenopausal women
Stromal hyperthecosis classically shows:
A. Bilateral uniform
ovarian enlargement
B. Unilateral ovarian atrophy
C. Small
ovaries with fibrosis
D. Calcified cortical plaques
A. Bilateral uniform ovarian enlargement
Microscopy in stromal hyperthecosis shows:
A. Koilocytosis with
halos
B. Caseating granulomas
C. Hypercellular stroma,
luteinization
D. Glands invading myometrium
C. Hypercellular stroma, luteinization
Virilization in stromal hyperthecosis is:
A. Less than
PCOS
B. More striking than PCOS
C. Absent versus
PCOS
D. Identical to PCOS
B. More striking than PCOS
Cystic ovarian follicles can arise from:
A. Luteal cyst
rupture
B. Teratoma degeneration
C. Tubal epithelial
rests
D. Unruptured Graafian follicles
D. Unruptured Graafian follicles
Cystic follicles can also form when follicles:
A. Rupture then
immediately seal
B. Never reach antral stage
C. Implant in
myometrium
D. Become malignant rapidly
A. Rupture then immediately seal
Most primary ovarian neoplasms derive from:
A. Germ cell
lineage
B. Müllerian epithelium
C. Smooth muscle
lineage
D. Neural crest lineage
B. Müllerian epithelium
Benign ovarian tumor with cystic areas:
A. Adenofibroma
B.
Cystadenofibroma
C. Cystadenoma
D. Borderline serous tumor
C. Cystadenoma
Benign ovarian tumor with mainly fibrous areas:
A.
Adenofibroma
B. Cystadenoma
C. Mature teratoma
D. Fibrosarcoma
A. Adenofibroma
Benign ovarian tumor with cystic and fibrous areas:
A.
Cystadenoma
B. Adenofibroma
C. Dysgerminoma
D. Cystadenofibroma
D. Cystadenofibroma
Stromal hyperthecosis is also called:
A.
Endosalpingiosis
B. Adenomyosis
C. Cortical stromal
hyperplasia
D. Endometrial atrophy
C. Cortical stromal hyperplasia
An ovarian tumor described as borderline/malignant with a cystic
component is:
A. Adenofibroma
B. Cystadenocarcinoma
C. Cystadenoma
D. Fibroma
B. Cystadenocarcinoma
Benign ovarian tumors are more common in:
A. Women age
20–45
B. Women age 45–65
C. Postmenopausal women
only
D. Prepubertal girls only
A. Women age 20–45
Malignant ovarian tumors are more common in:
A. Women age
20–45
B. Adolescents
C. Women age 45–65
D. Children
C. Women age 45–65
Type I ovarian carcinomas are typically:
A. Low-grade
tumors
B. High-grade serous tumors
C. Always mucinous
tumors
D. Always germ cell tumors
A. Low-grade tumors
Type I ovarian carcinomas often arise with:
A. Endometriosis or
borderline tumors
B. STIC lesions only
C. HPV-associated
lesions
D. Leiomyomas
A. Endometriosis or borderline tumors
Type II ovarian carcinomas are best described as:
A. Low-grade
endometrioid tumors
B. High-grade serous carcinomas
C.
Benign cystic neoplasms
D. Borderline mucinous tumors
B. High-grade serous carcinomas
Type II ovarian carcinomas arise from:
A. Endometriosis
implants
B. Serous borderline tumors
C. Serous
intraepithelial carcinoma
D. Granulosa cell tumors
C. Serous intraepithelial carcinoma
Most common malignant ovarian tumor type:
A. Serous
tumors
B. Mucinous tumors
C. Clear cell tumors
D.
Brenner tumors
A. Serous tumors
Serous tumors are typically:
A. Solid-only neoplasms
B.
Cystic neoplasms
C. Purely stromal tumors
D. Always
bilateral fibromas
B. Cystic neoplasms
Germline mutations increasing ovarian cancer risk include:
A.
PTEN and TP53
B. KRAS and BRAF
C. MLH1 and MSH2
D.
BRCA1 and BRCA2
D. BRCA1 and BRCA2
Low-grade serous carcinomas often arise with:
A. Serous
borderline tumors
B. STIC lesions
C. Endometriosis
only
D. Vaginal SCC
A. Serous borderline tumors
High-grade serous carcinomas often arise from:
A. Serous
borderline tumors
B. In situ lesions in fimbriae
C.
Ovarian fibromas
D. Cervical HSIL
B. In situ lesions in fimbriae
Serous tubal intraepithelial carcinoma (STIC) is associated with
sporadic:
A. Low-grade mucinous cancers
B. High-grade
serous ovarian cancers
C. Endometrioid hyperplasia
D. Leiomyosarcoma
B. High-grade serous ovarian cancers
Women with BRCA mutation and strong family history may undergo:
A. Prophylactic hysterectomy only
B. Prophylactic
salpingo-oophorectomy
C. Cervical conization
D.
Endometrial ablation
B. Prophylactic salpingo-oophorectomy
High-grade serous tumors commonly show mutations in:
A.
KRAS
B. BRAF
C. TP53
D. ERBB2
C. TP53
Low-grade serous tumors more often show mutations in:
A.
KRAS/BRAF/ERBB2
B. TP53
C. PTEN
D. APC
KRAS/BRAF/ERBB2
STIC lesions are identical to high-grade serous carcinoma except they
lack:
A. Necrosis
B. Papillary architecture
C.
Pleomorphism
D. Invasion
D. Invasion
Mucinous tumors occur most frequently in:
A. Childhood
B.
Middle adult life
C. After menopause
D. Before puberty
B. Middle adult life
Mucinous tumors rarely occur:
A. In middle adult life
B.
In adolescence only
C. Before puberty or after menopause
D. In reproductive years
C. Before puberty or after menopause
Mucinous tumors are:
A. Benign only
B. Borderline
mostly
C. Benign mostly
D. Borderline only
C. Benign mostly
A large unilateral ovarian mass shows mucinous epithelium. Which
mutation is most consistent?
A. TP53 mutation
B. KRAS
mutation
C. FOXL2 mutation
D. PTEN mutation
A. TP53 mutation
Which feature best fits mucinous ovarian tumors?
A. Surface
commonly involved
B. Usually bilateral disease
C. Diffuse
peritoneal implants
D. Surface rarely involved
D. Surface rarely involved
Histology shows tubular glands resembling endometrium. Tumor
type?
A. Endometrioid ovarian tumor
B. Serous
cystadenocarcinoma
C. Mucinous cystadenoma
D. Dysgerminoma
A. Endometrioid ovarian tumor
Endometrioid ovarian carcinomas may coexist with:
A.
PCOS
B. Salpingitis
C. Endometriosis
D. Leiomyomas
C. Endometriosis
Endometrioid carcinoma + endometriosis often share mutations
affecting:
A. Hedgehog and Wnt
B. PI3K/AKT and mismatch
repair
C. JAK/STAT and p53
D. EGFR and ALK
B. PI3K/AKT and mismatch repair
Endometrioid ovarian carcinomas are usually:
A. High-grade
tumors
B. Borderline only
C. Always metastatic
D.
Low-grade tumors
D. Low-grade tumors
Large epithelial cells with clear cytoplasm suggest:
A. Serous
carcinoma
B. Mucinous carcinoma
C. Clear cell
carcinoma
D. Transitional cell tumor
C. Clear cell carcinoma
Transitional cell tumors of the ovary are usually:
A.
Benign
B. Highly malignant
C. Always bilateral
D.
Always functional
A. Benign
Ovarian carcinoma seeds peritoneum via capsule. Expected
finding?
A. Hyperandrogenism
B. Chylous pleural
effusion
C. Pelvic inflammatory disease
D. Massive ascites
D. Massive ascites
Most ovarian carcinomas present with:
A. Cyclic bleeding
only
B. Lower abdominal pain, enlargement
C. Postcoital
spotting only
D. Acute fever and discharge
B. Lower abdominal pain, enlargement
Benign ovarian teratomas are commonly called:
A. Dermoid
cysts
B. Serous cysts
C. Brenner tumors
D. Krukenberg tumors
A. Dermoid cysts
Mature (benign) teratoma is occasionally linked to:
A.
Lambert-Eaton syndrome
B. Hashimoto encephalopathy
C.
Inflammatory limbic encephalitis
D. Guillain-Barré syndrome
C. Inflammatory limbic encephalitis
A teratoma causes flushing and wheeze. Most likely syndrome?
A.
Cushing syndrome
B. Carcinoid syndrome
C. Turner
syndrome
D. Conn syndrome
B. Carcinoid syndrome
An 18-year-old has malignant ovarian teratoma. Type?
A. Immature
teratoma
B. Mature teratoma
C. Struma ovarii
D. Dermoid cyst
A. Immature teratoma
Most dysgerminomas are:
A. Bilateral tumors
B. Multifocal
tumors
C. Capsular-seeding tumors
D. Unilateral tumors
D. Unilateral tumors
Rapidly growing pelvic mass in a child suggests:
A. Brenner
tumor
B. Thecoma
C. Yolk sac tumor
D. Endometrioma
C. Yolk sac tumor
Ovarian choriocarcinoma (nongestational) is typically:
A.
Chemo-sensitive, favorable outcome
B. Chemo-resistant, often
fatal
C. Slow-growing, indolent course
D. Benign, hormonally silent
B. Chemo-resistant, often fatal
Granulosa cell tumors are usually:
A. Benign, potentially
malignant
B. Bilateral, potentially malignant
C.
Nonfunctional, potentially malignant
D. Unilateral, potentially malignant
D. Unilateral, potentially malignant
FOXL2 mutations are common in:
A. Adult granulosa tumors
B.
Yolk sac tumors
C. Mucinous carcinomas
D. Dysgerminomas
A. Adult granulosa tumors
Tumors composed predominantly of theca cells are:
A. Usually
malignant
B. Usually borderline
C. Almost always
benign
D. Always metastatic
C. Almost always benign
Plump spindle stromal cells with lipid droplets indicates:
A.
Fibroma
B. Thecoma
C. Dysgerminoma
D. Brenner tumor
B. Thecoma
Most fibromas, fibrothecomas, and thecomas are:
A.
Benign
B. Highly malignant
C. Always bilateral
D. Often metastatic
A. Benign
Over half of Sertoli-Leydig tumors show mutation in:
A.
KRAS
B. TP53
C. FOXL2
D. DICER1
D. DICER1
DICER1 mutations primarily disrupt:
A. DNA mismatch
repair
B. Steroid receptor binding
C. microRNA
regulation
D. Collagen cross-linking
C. microRNA regulation
A pregnancy-associated ovarian mass mimics corpus luteum.
Diagnosis?
A. Pregnancy luteoma
B. Krukenberg tumor
C.
STIC lesion
D. Endometrioma
A. Pregnancy luteoma
Pregnancy luteoma may cause:
A. Maternal hypocalcemia
B.
Virilization in female infants
C. Severe
hyperprolactinemia
D. Autoimmune oophoritis
B. Virilization in female infants
Metastatic GI carcinoma to ovaries is termed:
A. Brenner
tumor
B. Dermoid cyst
C. Krukenberg tumor
D. Thecoma
C. Krukenberg tumor
Krukenberg tumor is classically:
A. Unilateral, serous
papillary
B. Pure squamous morphology
C. Clear-cell,
endometrial-type
D. Bilateral mucin signet-ring cells
D. Bilateral mucin signet-ring cells
In mucinous ovarian tumors, laterality is most often:
A.
Unilateral
B. Bilateral
C. Diffusely multifocal
D.
Always midline
A. Unilateral
Clear cell ovarian carcinoma most resembles:
A. Secretory-phase
normal endometrium
B. Hypersecretory gestation
endometrium
C. Atrophic endometrium
D. Proliferative-phase endometrium
B. Hypersecretory gestation endometrium